Whitfield Recognized in The Lawyer’s “Top 20 Cases of 2026”

Award   ·   16 January 2026

Overview

The Lawyer’s anticipated cases list for 2026 includes a patent dispute between Boehringer Ingelheim and Dr Reddy’s Laboratories, according to the source.

Patent subject

The notice connects the litigation to patents concerning Boehringer’s diabetes medication, placing it within pharmaceutical intellectual-property disputes.

Named team

Nicola Dagg, Steven Baldwin, Jin Ooi and Oscar Robinson are the partners identified as proposed counsel for Boehringer Ingelheim.

Procedural status

The article describes a case expected to attract attention during the year, rather than a completed judgment. The summary does not infer a ruling, damages figure or independently verified advisory role from that anticipated significance.